Skip to main content
. 2017 Sep 30;8(54):92483–92496. doi: 10.18632/oncotarget.21426

Figure 4. Impact of CTC methylation on progression-free survival (PFS) in metastatic breast cancer patients.

Figure 4

PFS for patients with CST6, ITIH5, and RASSF1 methylation. black line, CTCs methylated, grey line, CTCs unmethylated.